leptin and Takayasu-Arteritis

leptin has been researched along with Takayasu-Arteritis* in 3 studies

Other Studies

3 other study(ies) available for leptin and Takayasu-Arteritis

ArticleYear
Exploration of molecular signatures associated with different clinical features of Takayasu arteritis based on a prospective cohort study.
    Clinical immunology (Orlando, Fla.), 2023, Volume: 256

    Takayasu arteritis (TAK) is complicated disorder without reliable biomarkers. Here, we aimed to explore TAK-associated factor panels and their changes after biologic treatment. Five factor panels were identified: 1. systemic inflammation: C3, ESR, CRP, PLT, IL-6, C4, and IgG; 2. vascular inflammation: YKL40, IL-16, PTX3, and CCL2; 3. immune regulation panel: IL-10, IFN-γ, CCL5, and MMP1; 4. angiogenesis and fibrosis: FGF, PDGFAB, and VEGF; and 5. vascular remodeling: CD19+ B cell ratio, MMP3, and leptin. Panel 1 parameters were closely related to disease activity, while Panel 5 parameters, particularly CD19+ B cell ratio and leptin, were significantly higher in ischemic patients. After treatment, tocilizumab had a stronger inhibitory effect on Panel 1 parameters, PTX3, and YKL-40, while adalimumab led to an increase in IL-16, CCL2, and leptin levels. Altogether, these data expanded our knowledge regarding molecular background in TAK development and shed light on precise treatment in future studies.

    Topics: Humans; Inflammation; Interleukin-16; Leptin; Prospective Studies; Takayasu Arteritis

2023
Serum leptin, a potential predictor of long-term angiographic progression in Takayasu's arteritis.
    International journal of rheumatic diseases, 2019, Volume: 22, Issue:12

    In patients with Takayasu's arteritis (TA), current biomarkers that properly reflect the progression of the vascular structure remain absent. We aimed to determine the serum leptin level to investigate its relationship with imaging changes and assess its value as a predictor for long-term radiological progression.. This study included 34 untreated TA patients and 40 age-matched healthy controls. At baseline and during the 5-year follow-up, we assessed disease activity using Kerr's criteria and Indian Takayasu Clinical Activity Score (ITAS2010) and monitored laboratory biomarkers as well as imaging findings. Serum leptin levels were measured by enzyme-linked immunosorbent assay.. The baseline serum leptin levels were significantly higher in TA patients than in healthy controls. Leptin was significantly positively correlated with triglyceride and high-density lipoprotein cholesterol levels and negatively correlated with fibrinogen and C-reactive protein levels. Patients were subdivided into three groups based on their baseline leptin level. During a 5-year follow-up, patients in the high and medium leptin groups showed more radiological progression compared to those in the low leptin group. Cox proportional hazard regression analysis showed that a high serum leptin level was a positive predictor of radiological progression.. Leptin is a potential biomarker for assessing TA structural progression. Untreated patients with elevated serum leptin levels are at a higher risk of progression in the aorta. Thus, the leptin level can be a predictor of long-term radiological progression.

    Topics: Adolescent; Adult; Angiography; Biomarkers; Case-Control Studies; Child; Cross-Sectional Studies; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Humans; Leptin; Middle Aged; Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors; Takayasu Arteritis; Time Factors; Up-Regulation; Young Adult

2019
Ghrelin and adipokines as circulating markers of disease activity in patients with Takayasu arteritis.
    Arthritis research & therapy, 2012, Dec-21, Volume: 14, Issue:6

    The current markers of disease activity in Takayasu arteritis (TA) are insufficient for proper assessment. We investigated circulating levels of unacylated and acylated ghrelin, leptin and adiponectin and their relationships with disease activity in patients with TA.. This study included 31 patients with TA and 32 sex-, age- and body mass index-matched healthy controls. Disease activity was assessed in TA patients using various tools, including Kerr's criteria, disease extent index-Takayasu, physician's global assessment, radiological parameters, and laboratory markers. Plasma unacylated and acylated ghrelin, and serum leptin and adiponectin levels were measured using an enzyme-linked immunosorbent assay.. Unacylated and acylated ghrelin levels were found to be significantly lower in TA patients than that in healthy controls. Patients with active disease had lower unacylated ghrelin levels than those with inactive disease and had lower acylated ghrelin levels than healthy controls. Ghrelin levels were negatively correlated with various parameters of disease activity. The leptin/ghrelin ratio was significantly higher in TA patients than controls. It was positively correlated with disease activity. There was a positive correlation between unacylated and acylated ghrelin and a negative correlation between leptin and ghrelin. There was no statistical difference in adiponectin levels between TA patients and controls. The radiological activity markers were positively correlated with other parameters of disease activity.. This study suggests that plasma unacylated and acylated ghrelin levels may be useful in monitoring disease activity and planning treatment strategies for patients with TA. The serum leptin level and leptin/ghrelin ratio may also be used to help assess the disease activity.

    Topics: Acylation; Adiponectin; Adult; Biomarkers; Body Mass Index; Carotid Arteries; Carotid Intima-Media Thickness; Enzyme-Linked Immunosorbent Assay; Female; Ghrelin; Glucocorticoids; Humans; Leptin; Male; Middle Aged; Outcome Assessment, Health Care; Takayasu Arteritis; Waist Circumference; Waist-Hip Ratio

2012